Cpcr Technology is categorized under Research and Development Laboratories in Lubbock, TX and active since 2009.
Cpcr Technology was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 8112120 by the NAICS.
If you are seeking more information, feel free to contact Christopher Hefner, Owner at the company’s single location by writing to 4200 Boston Avenue, Lubbock, Texas TX 79413 or by phoning (806) 712-2727. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cpcr Technology |
| Contact Person: | Christopher Hefner, Owner |
| Address: | 4200 Boston Avenue, Lubbock, Texas 79413 |
| Phone Number: | (806) 712-2727 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 8112120 |
| Share This Business: |
Cpcr Technology was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 8112120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Hefner, Owner for inquiries that concern Cpcr Technology by calling the company number (806) 712-2727, as your correspondence is most welcome. Additionally, the physical location of the single location of Cpcr Technology can be found at the coordinates 33.55578,-101.87479 as well as the street address 4200 Boston Avenue in Lubbock, Texas 79413.
For its online presence, you may visit Cpcr Technology’s website at and engage with its social media outlets through on Twitter and on Facebook.